Developing and testing the effectiveness of treatments for co-occurring substance use disorders and severe mental illness. Public health research and behavioral interventions in American Indian and Alaska Native communities. The use of ethyl glucuronide, a biomarker of recent alcohol use, as a component in contingency management interventions for people diagnosed with alcohol use disorders. Research on the assessment and treatment of of children with severe psychiatric disorders who receive care in the public mental health system.
Development of evidence-based substance use disorder treatments, innovative analytical methods to answer novel research questions in psychopharmacology and substance abuse, substance use disorders as a complicating co-morbidity.